Repeat dosing of albuterol via metered-dose inhaler in infants with acute obstructive airway disease: A randomized controlled safety trial

Pediatric Emergency Care

Volumn 26, Issue 3, 2010, Pages 197-202

  Kaashmiri, Mohammed ^a   Shepard, Julie ^b   Goodman, Brad ^c   Lincourt, William R ^d   Trivedi, Roopa ^d   Ellsworth, Anna ^d   Davis, Angela M ^d  

^a St Elizabeth Medical Center   (United States)

^b Ohio Pediatrics Inc   (United States)

^c Aeroallergy Research Labs of Savannah   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Albuterol; Face mask; Hydrofluoroalkane; Spacer

Indexed keywords

GLUCOSE; PLACEBO; POTASSIUM; SALBUTAMOL SULFATE;

ADRENERGIC STIMULATION; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPOKALEMIA; INFANT; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; OBSTRUCTIVE AIRWAY DISEASE; POTASSIUM BLOOD LEVEL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; SUPRAVENTRICULAR PREMATURE BEAT; TACHYCARDIA; WHEEZING;

ADMINISTRATION, INHALATION; AEROSOLS; ALBUTEROL; BRONCHODILATOR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROCARBONS, FLUORINATED; INFANT; INFANT, NEWBORN; LUNG DISEASES, OBSTRUCTIVE; MALE; MASKS; METERED DOSE INHALERS; RESPIRATORY SOUNDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77949407058     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/PEC.0b013e3181d1e40d     Document Type: Article

References (33)

1. Akinbami LJ. The state of childhood asthma, United States, 1980-2005. Advance Data From Vital and Health Statistics; No.381. Hyattsville, MD: National Center for Health Statistics; 2006.
2. Martinez FD. Viruses and atopic sensitization in the first years of life. Am J Respir Crit Care Med. 2000;162:595-599.
3. Moorman JE, Rudd RA, Johnson CA, et al. National surveillance for asthmaVUnited States, 1980-2004. MMWR Morb Mortal Wkly Rep. 2007;56:1-54.
4. Bronchodilators and other medications for the treatment of wheeze-associated illnesses in young children. Programme for the Control of Acute Respiratory Infections World Health Organization Geneva WHO/ARI/93.29. July 2006.
5. National Asthma Education and Prevention Program (NAEPP). Guidelines for the Diagnosis and Management of Asthma [Expert Panel Report 3. NIH Publication 08 4051]. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 2007.
6. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Available at: www.ginasthma.org. Accessed January 12, 2008.
7. Blake KV, Hoppe M, Harman E, et al. Relative amount of albuterol delivered to lung receptors from a metered-dose inhaler and nebulizer solution. Bioassay by histamine bronchoprovocation. Chest. 1992;101:309-315.
8. Bowton DL, Goldsmith WM, Haponik EF. Substitution of metered dose inhalers for hand held nebulizers. Success and cost savings in a large, acute care hospital. Chest. 1992;101:305-308.
9. Chou KJ, Cunningham SJ, Crain EF. Metered-dose inhalers with spacers vs nebulizers for pediatric asthma. Arch Pediatr Adolesc Med. 1995;149:201-205.
10. Leversha AM, Campanella SG, Aickin RP, et al. Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma. J Pediatr. 2000;136:497-502.
11. Summer W, Elston R, Tharpe L, et al. Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care. Arch Int Med. 1989;149:618-623.
12. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database of Systematic Reviews 1, 2006.
13. Amirav I, Newhouse MT. Metered dose-inhaler accessory devices in acute asthma: efficacy and comparison with nebulizers: a literature review. Arch Pediatr Adolesc Med. 1997;151:876-882.
14. Delgado A, Chou KJ, Silver EJ, et al. Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. Arch Pediatr Adolesc Med. 2003;157:76-80.
15. Pavon D, Castro-Rodriguez JA, Rubilar L, et al. Relation between pulse oximetry and clinical score in children with acute wheezing less than 24 months of age. Pediatr Pulmonol. 1999;27:423-427.
16. Kerem E, Levison H, Schuh S, et al. Efficacy of albuterol administered by nebulizer versus spacer in children with acute asthma. J Pediatr. 1993;123:313-317.
17. Schuh S, Johnson DW, Stephens D, et al. Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma. J Pediatr. 1999;135:22-27.
18. Ploin D, Chapuis FR, Stamm D, et al. High-dose albuterol by metered-dose inhaler plus a spacer device versus nebulization in preschool children with recurrent wheezing: a double-blind, randomized equivalence trial. Pediatrics. 2000;106:311-317.
19. Benito-Fernandez J, Gonzalez-Balenciaga M, Capape-Zache S, et al. Salbutamol via metered-dose inhaler with spacer versus nebulization for acute treatment of pediatric asthma in the emergency department. Pediatr Emerg Care. 2004;20(10):656-659.
20. Castro-Rodriguez JA, Rodrigo GJ. A-Agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J Pediatr. 2004;145:172-177.
21. Rubilar L, Castro-Rodriguez JA, Girardi G. Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age. Pediatr Pulmonol. 2000;29:264-269.
22. Closa RM, Ceballos JM, Gomez-Papi A, et al. Efficacy of bronchodilators administered by nebulizers versus spacer devices in infants with acute wheezing. Pediatr Pulmonol. 1998;26:344-348.
23. Mallol J, Barrueto L, Girardi G, et al. Bronchodilator effect of fenoterol and ipratropium bromide in infants with acute wheezing: use of MDI with a spacer device. Pediatr Pulmonol. 1987;3:352-356.
24. Margolis PA, Ferkol TW, Marsocci S, et al. Accuracy of the clinical examination in detecting hypoxemia in infants with respiratory illness. J Pediatr. 1994;124:552-560.
25. Wang EE, Milner RA, Navas L, et al. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis. 1992;145:106-109.
26. Deerojanawong J, Manuyakorn W, Prapphal N, et al. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs jet nebulizer in young children with wheezing. Pediatr Pulmonol. 2005;39:466-472.
27. Lipworth BJ, McDevitt DG. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol. 1989;36:239-245.
28. Wong CS, Pavord ID, Williams J, et al. Bronchodilator, cardiovascular and hypokalemic effects of fenoterol, salbutamol and terbutaline in asthma. Lancet. 1990;336:1396-1399.
29. Bremner P, Woodman K, Burgess C, et al. A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol. Eur Respir J. 1993;6:204-210.
30. Del Rio-Navarro B, Gazca-Aguilar A, Quibrera Matienzo JA, et al. Metabolic and electrocardiography effects of albuterol in pediatric asthmatic patients treated in an emergency room setting. Allergol Immunopathol (Madr). 1999;27:18-23.
31. Shrestha M, Bidadi K, Gourlay S, et al. Continuous vs intermittent albuterol, at high and low doses, in the treatment of severe acute asthma in adults. Chest. 1996;110:42-47.
32. Emerman CL, Cydulka RK, McFadden ER. Comparison of 2.5 vs 7.5 mg of inhaled albuterol in the treatment of acute asthma. Chest. 1999;115:92-96.
33. Hung C-H, Chu D-M, Wang C-L, et al. Hypokalemia and salbutamol therapy in asthma. Pediatr Pulmonol. 1999;27:27-31.